Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 1093-1098

  Shih, Liang Chun ^a   Tsai, Chia Wen ^a,b   Tsai, Ming Hsui ^a   Tsou, Yung A N ^a   Chang, Wen Shin ^a,b   Li, Fang Jing ^a   Lee, Meng Hsuan ^a,b   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cyclin d1; Nasopharyngeal carcinoma; Polymorphism; Smoking habit

Indexed keywords

CYCLIN D1;

ADULT; ALLELE; ARTICLE; CANCER RISK; CELL CYCLE REGULATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SMOKING HABIT;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; CYCLIN D1; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TAIWAN;

EID: 84863346995     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Chan AT, Teo PM and Johnson PJ: Nasopharyngeal carcinoma. Ann Oncol 13: 1007-1015, 2002.
2. Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429, 2002. (Pubitemid 35370755)
3. Department of Health, Taiwan: Cancer Registration System Annual Report. Taiwan, Department of Health, 2010.
4. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A and Anagnostopoulos I: Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 165: 17-24, 1991.
5. Zong YS, Sham JS, Ng MH, Ou XT, Guo YQ, Zheng SA, Liang JS and Qiu H: Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer 69: 3-7, 1992.
6. Mirabelli MC, Hoppin JA, Tolbert PE, Herrick RF, Gnepp DR and Brann EA: Occupational exposure to chlorophenol and the risk of nasal and nasopharyngeal cancers among U.S. men aged 30 to 60. Am J Ind Med 37: 532-541, 2000. (Pubitemid 30193756)
7. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC and Sani S: Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer 77: 228-235, 1998. (Pubitemid 28287975)
8. Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, Feng QS, Huang LX, Yu XJ, Li D, Chen LZ, Jia WH, Fang Y, Huang HM, Zhu JL, Liu XM, Zhao Y, Liu WQ, Deng MQ, Hu WH, Wu SX, Mo HY, Hong MF, King MC, Chen Z and Zeng YX: Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 31: 395-399, 2002. (Pubitemid 35154449)
9. Feng XL, Zhou W, Li H, Fang WY, Zhou YB, Yao KT and Ren CP: The DLC-1 -29A/T polymorphism is not associated with nasopharyngeal carcinoma risk in Chinese population. Genet Test 12: 345-349, 2008.
10. Chen L, Elahi A, Pow-Sang J, Lazarus P and Park J: Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol 170: 2471-2474, 2003. (Pubitemid 37414037)
11. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleecker ER, Walsh PC, Meyers DA and Isaacs WB: Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 62: 2253-2257, 2002. (Pubitemid 34411700)
12. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
13. Sherr CJ: D-Type cyclins. Trends Biochem Sci 20: 187-190, 1995.
14. Coqueret O: Linking cyclins to transcriptional control. Gene 299: 35-55, 2002.
15. Fu M, Wang C, Li Z, Sakamaki T and Pestell RG: Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447, 2004. (Pubitemid 39564581)
16. Jayasurya R, Sathyan KM, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, Nair MK and Kannan S: Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol 18: 1056-1066, 2005. (Pubitemid 41224496)
17. INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 5: 2810-2819, 1999.
18. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
19. Holley SL, Parkes G, Matthias C, Bockmuhl U, Jahnke V, Leder K, Strange RC, Fryer AA and Hoban PR: Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159: 1917-1924, 2001. (Pubitemid 33062533)
20. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman SM and Wu X: Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 27: 2034-2037, 2006. (Pubitemid 44530578)
21. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 42: 607-613, 2006. (Pubitemid 43947667)
22. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol 44: 689-697, 2008. (Pubitemid 351842821)
23. Chang CH, Chiu CF, Wang HC, Wu HC, Tsai RY, Tsai CW, Wang RF, Wang CH, Tsou YA and Bau DT: Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 5121-5124, 2009.
24. Chang CH, Wang RF, Tsai RY, Wu HC, Wang CH, Tsai CW, Chang CL, Tsou YA, Liu CS and Bau DT: Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 3903-3907, 2009.
25. Liu CJ, Hsia TC, Wang RF, Tsai CW, Chu CC, Hang LW, Wang CH, Lee HZ, Tsai RY and Bau DT: Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients. Anticancer Res 30: 1195-1199, 2010.
26. Liu CS, Tsai CW, Hsia TC, Wang RF, Liu CJ, Hang LW, Chiang SY, Wang CH, Tsai RY, Lin CC and Bau DT: Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics 6: 325-329, 2009.
27. Wang HC, Chiu CF, Tsai RY, Kuo YS, Chen HS, Wang RF, Tsai CW, Chang CH, Lin CC and Bau DT: Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. Anticancer Res 29: 3897-3901, 2009.
28. Yang MD, Hsu YM, Kuo YS, Chen HS, Chang CL, Wu CN, Chang CH, Liao YM, Wang HC, Wang MF and Bau DT: Significant association of KU80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. Anticancer Res 29: 2239-2242, 2009.
29. Chang CH, Chiu CF, Liang SY, Wu HC, Chang CL, Tsai CW, Wang HC, Lee HZ and Bau DT: Significant association of KU80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 1275-1279, 2009.
30. Akkiz H, Bayram S, Bekar A, Akgollu E and Ozdil B: Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 34: 298-302, 2010.
31. Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W and Szyfter K: Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol 263: 43-48, 2006. (Pubitemid 43004710)
32. Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E and Unal H: CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res 30: 3093-3098, 2010.
33. Jiang J, Wang J, Suzuki S, Gajalakshmi V, Kuriki K, Zhao Y, Nakamura S, Akasaka S, Ishikawa H and Tokudome S: Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 132: 193-199, 2006. (Pubitemid 43015780)
34. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, Schulte-Witte H, Plassmann D, Rahner N, Aretz S, Friedrichs N, Buettner R, Sauerbruch T and Lammert F: Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23: 147-154, 2008. (Pubitemid 350302510)
35. Yuan L, Gu X, Shao J, Wang M, Zhu Q and Zhang Z: Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol 29: 611-617, 2010.
36. Yaylim-Eraltan I, Arikan S, Yildiz Y, Cacina C, Ergen HA, Tuna G, Gormus U, Zeybek U and Isbir T: The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res 30: 2875-2880, 2010.
37. Gomes CC, Drummond SN, Guimaraes AL, Andrade CI, Mesquita RA and Gomez RS: P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med 37: 151-156, 2008. (Pubitemid 351178410)
38. Gangwar R and Mittal RD: Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population. DNA Cell Biol 29: 349-356, 2010.
39. Jain M, Kumar S, Upadhyay R, Lal P, Tiwari A, Ghoshal UC and Mittal B: Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer Biol Ther 6: 1553-1558, 2007. (Pubitemid 351590326)
40. Satinder K, Chander SR, Pushpinder K, Indu G and Veena J: Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case-control study in north Indian population. Mol Cell Biochem 315: 151-157, 2008.
41. Jayasurya R, Francis G, Kannan S, Lekshminarayanan K, Nalinakumari KR, Abraham T, Abraham EK and Nair MK: p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma. Int J Cancer 109: 710-716, 2004. (Pubitemid 38405618)
42. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD and Heighway J: Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011, 1995.
43. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, Hara M and Saito I: Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16: 1701-1712, 1998. (Pubitemid 28175051)
44. Izzo JG, Wu TT, Wu X, Ensor J, Luthra R, Pan J, Correa A, Swisher SG, Chao CK, Hittelman WN and Ajani JA: Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol 25: 698-707, 2007. (Pubitemid 350002926)